Cargando…

NSAIDs do not increase risk or severity of COVID-19 infections

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360809/ http://dx.doi.org/10.1007/s40278-021-00466-8

Ejemplares similares

Do NSAIDs increase the severity of COVID-19?
Publicado: (2021)

NSAIDs do not increase risk of death in adults hospitalised with influenza
Publicado: (2020)

NSAID use does not increase risk of COVID-19-related death
Publicado: (2021)

ACEI inhibitors and ARBs do not increase severity of COVID-19
Publicado: (2020)

NSAIDs-Related Pyloroduodenal Obstruction and Its Endoscopic Management
por: Noor, Mohd Talha, et al.
Publicado: (2011)

The Role of Helicobacter pylori and NSAIDs in the Pathogenesis of Uncomplicated Duodenal Ulcer
por: Cekin, Ayhan Hilmi, et al.
Publicado: (2012)

Analgesia Evaluation of 2 NSAID Drugs as Adjuvant in Management of Chronic Temporomandibular Disorders
por: Kurita Varoli, Fernando, et al.
Publicado: (2015)

Do Nonsteroidal Anti-Inflammatory Drugs Cause Endoprosthetic Loosening? Mid- to Long-Term Follow-Up of 100 Total Hip Arthroplasties after Local NSAID Infiltration
por: Nizam, Ikram, et al.
Publicado: (2015)

Biological or targeted synthetic DMARDs increase COVID-19 severity
Publicado: (2021)

Inverse association of NSAID use and ovarian cancer in relation to oral contraceptive use and parity
por: Wernli, K J, et al.
Publicado: (2008)

NSAIDs may increase the risk of thrombosis and acute renal failure in patients with COVID-19 infection
por: Cumhur Cure, Medine, et al.
Publicado: (2020)

Pre-diagnostic NSAID use but not hormone therapy is associated with improved colorectal cancer survival in women
por: Coghill, A E, et al.
Publicado: (2011)

Mesenchymal Stromal Cells Do Not Increase the Risk of Viral Reactivation Nor the Severity of Viral Events in Recipients of Allogeneic Stem Cell Transplantation
por: Lucchini, Giovanna, et al.
Publicado: (2012)

Proton pump inhibitors increase risk of COVID-19
Publicado: (2020)

Chloroquine and hydroxychloroquine increase risk of death in COVID-19
Publicado: (2020)

No increased risk for venous thromboembolism after COVID-19 vaccination
Publicado: (2022)

A Clinical Study on Glucosamine Sulfate versus Combination of Glucosamine Sulfate and NSAIDs in Mild to Moderate Knee Osteoarthritis
por: Selvan, Tamil, et al.
Publicado: (2012)

Safe use of paracetamol and high-dose NSAID analgesia in dentistry during the COVID-19 pandemic
por: Crighton, Alexander J., et al.
Publicado: (2020)

Effective NSAID treatment indicates that hyperprostaglandinism is affecting the clinical severity of childhood hypophosphatasia
por: Girschick, HJ, et al.
Publicado: (2006)

NSAID-Induced Enteropathy in Rheumatoid Arthritis Patients with Chronic Occult Gastrointestinal Bleeding: A Prospective Capsule Endoscopy Study
por: Tachecí, Ilja, et al.
Publicado: (2013)

The Effect of NSAID Pretreatment on Aqueous Humor Prostaglandin E(2) Concentration in Eyes Undergoing Femtosecond Laser-Assisted Capsulotomy
por: Diakonis, Vasilios F., et al.
Publicado: (2018)

Remdesivir does not increase risk of AKI or ALI in COVID-19 patients
Publicado: (2022)

Increased risk of immune thrombocytopenia following AstraZeneca Covid-19 vaccine
Publicado: (2021)

Do Clopidogrel Nonresponders Have an Increased Risk of Adverse Events during Supra-Aortal Angioplasty and Stenting?
por: Koerner, Heiko, et al.
Publicado: (2012)

Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study
por: Subramanian, Anuradhaa, et al.
Publicado: (2021)

NSAIDs for analgesia in the era of COVID-19
por: Herzberg, Daniel L, et al.
Publicado: (2020)

Prevalence, severity, outcomes, and risk factors of COVID-19 in multiple sclerosis: An observational study in the Middle East
por: Alroughani, Raed, et al.
Publicado: (2022)

Hypophosphatemia is an independent risk factor for AKI among hospitalized patients with COVID-19 infection
por: Chen, Zijin, et al.
Publicado: (2021)

Cardiac risks higher after COVID-19 infection than mRNA vaccine
Publicado: (2022)

Remdesivir cost effective for severe COVID-19 in China
Publicado: (2021)

The effect of the severity of COVID-19 on the sequelae of the audiovestibular system
por: Aydin, Sukru, et al.
Publicado: (2022)

Tolerance to coxibs in patients with intolerance to non-steroidal anti-inflammatory drugs (NSAIDs): a systematic structured review of the literature
por: Weberschock, Tobias Bernd, et al.
Publicado: (2007)

NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators?
por: Capuano, Annalisa, et al.
Publicado: (2020)

Do NSAIDs Really Interfere with Healing after Surgery?
por: Schug, Stephan A.
Publicado: (2021)

AstraZeneca COVID-19 vaccine: no increased rate of VTE
Publicado: (2021)

COVID-19 vaccination during pregnancy: no increase in placental lesions
Publicado: (2021)

NSAIDs not linked to worse COVID-19 outcomes
por: Onuora, Sarah
Publicado: (2021)

COVID-19 and NSAIDs: Primum non nocere
por: Micallef, Joëlle, et al.
Publicado: (2020)

Covid-19—The real role of NSAIDs in Italy
por: de Girolamo, Laura, et al.
Publicado: (2020)

Effect of the Duration of NSAID Use on COVID-19
por: Kim, Kyeongmi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6hat3sk2kkl172crk5fjpja14k